CYRIL RUWENDE, MB,CHB,DPHIL
Osteopathic Medicine at Elliott Dr, Ypsilanti, MI

License number
Michigan 4301081101
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Michigan 4301081101
Category
Osteopathic Medicine
Type
Cardiovascular Disease
License number
Michigan 4301081101
Category
Osteopathic Medicine
Type
Interventional Cardiology
Address
Address 2
5325 Elliott Dr, Ypsilanti, MI 48197
24 - Lobby J, Ann Arbor, MI 48105
Phone
(734) 712-8000
(734) 712-4429 (Fax)
(734) 747-6766
(734) 222-3100 (Fax)

Personal information

See more information about CYRIL RUWENDE at radaris.com
Name
Address
Phone
Cyril Ruwende, age 57
4889 Gullane Dr, Ann Arbor, MI 48103
(734) 332-1722
Cyril D Ruwende, age 57
4889 Gullane Dr, Scio Township, MI 48103
(734) 332-1722

Professional information

See more information about CYRIL RUWENDE at trustoria.com
Cyril Ruwende Photo 1
Dr. Cyril Ruwende, Jackson MI - MD (Doctor of Medicine)

Dr. Cyril Ruwende, Jackson MI - MD (Doctor of Medicine)

Specialties:
Cardiology, Interventional Cardiology
Address:
Michigan Heart
309 Page Ave, Jackson 49201
(517) 787-1234 (Phone)
Michigan Heart
5325 Elliott Dr SUITE 2, Ypsilanti 48197
(734) 712-8000 (Phone)
Procedures:
Ablation for Treatment of Cardiac Arrythmias, Cardiac Catheterization (incl. Coronary Angiography), Cardiac Imaging, Cardiac Myocardial Perfusion Imaging, Cardioversion, Elective, Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair, Carotid Artery Stent Placement, Chest CT (incl. Heart and Lungs), Coronary Angioplasty, Atherectomy and Stent, Non-Coronary Angioplasty, Atherectomy, and Stenting, Peripheral Artery Catheterization, Thoracentesis, Tilt Testing or Cardiac Event Monitors
Conditions:
Aneurysm and Dissection of Heart, Angina and Acute Coronary Syndrome, Aortic Aneurysm, Aortic Ectasia, Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Autonomic Disorders, Cardiomegaly, Cardiomyopathy, Carotid Artery Disease, Congenital Heart Disease, Congestive Heart Failure, Coronary Artery Disease (CAD), Heart Attack (Acute Myocardial Infarction), Hyperlipidemia, Hypertension, Hypertensive Heart and Chronic Kidney Disease, Hypertensive Heart Disease, Hypotension, Mitral Valve Disease, Pericardial Disease, Pulmonary Hypertension, Pulmonary Valve Disease, Secondary Hypertension, Septal Defect, Syncope, Tricuspid Valve Disease
Certifications:
Cardiovascular Disease, 2012, Internal Medicine, 1999, Interventional Cardiology, 2013
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Michigan Heart
309 Page Ave, Jackson 49201
Michigan Heart
5325 Elliott Dr SUITE 2, Ypsilanti 48197
Saint Joseph Mercy Hospital
5301 Mcauley Dr, Ypsilanti 48197
Saint Mary Mercy Hospital
36475 5 Mile Rd, Livonia 48154
Allegiance Health
205 North East Ave, Jackson 49201
Saint Joseph Mercy Port Huron
2601 Electric Ave, Port Huron 48060
Education:
Medical School
Oxford University Medical School
Johns Hopkins Univ


Cyril Ruwende Photo 2
Tissue Inhibitor Of Metalloproteinase (Timp) As A Marker And Predictor Of Cardiovascular Disease And Both Cardiac And Non-Cardiac Mortality

Tissue Inhibitor Of Metalloproteinase (Timp) As A Marker And Predictor Of Cardiovascular Disease And Both Cardiac And Non-Cardiac Mortality

US Patent:
2006016, Jul 20, 2006
Filed:
Dec 1, 2005
Appl. No.:
11/292031
Inventors:
Erdal Cavusoglu - Douglaston NY, US
Jonathan Marmur - New York NY, US
David Pinsky - Ann Arbor MI, US
Cyril Ruwende - Ann Arbor MI, US
International Classification:
C12Q 1/68, G01N 33/53, G01N 33/00
US Classification:
435006000, 435007100, 436086000
Abstract:
The present invention is directed to a method for characterizing an individual's risk profile of developing vascular disease, for an adverse outcome in a patient, for mortality in an individual diagnosed with vascular disease by evaluating the level of tissue inhibitor of metalloproteinase-1 (TIMP-1) in a sample taken from the individual. The invention is also directed to a kit for characterizing the same.